$VTNRQ

2014 Q2 Form 10-Q Financial Statement

#000144530514003679 Filed on August 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $72.08M $35.11M
YoY Change 105.29% 12.21%
Cost Of Revenue $63.84M $32.56M
YoY Change 96.1% 6.6%
Gross Profit $8.235M $2.555M
YoY Change 222.35% 240.62%
Gross Profit Margin 11.42% 7.28%
Selling, General & Admin $7.391M $2.396M
YoY Change 208.52% 160.41%
% of Gross Profit 89.75% 93.78%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.070M $540.0K
YoY Change 98.15% 1250.0%
% of Gross Profit 12.99% 21.14%
Operating Expenses $7.391M $2.396M
YoY Change 208.52% 160.41%
Operating Profit $843.7K $2.009M
YoY Change -58.0% -1281.72%
Interest Expense $657.2K $113.0K
YoY Change 481.63%
% of Operating Profit 77.89% 5.62%
Other Income/Expense, Net $5.813M -$105.4K
YoY Change -5615.09%
Pretax Income $6.657M $1.904M
YoY Change 249.71% -1219.72%
Income Tax $0.00 $12.25K
% Of Pretax Income 0.0% 0.64%
Net Earnings $7.001M $1.891M
YoY Change 270.18% -1282.04%
Net Earnings / Revenue 9.71% 5.39%
Basic Earnings Per Share $0.31 $0.11
Diluted Earnings Per Share $0.28 $0.10
COMMON SHARES
Basic Shares Outstanding 22.83M shares 17.41M shares
Diluted Shares Outstanding 24.85M shares 19.89M shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.70M $300.0K
YoY Change 6466.67% -92.86%
Cash & Equivalents $19.65M $297.2K
Short-Term Investments
Other Short-Term Assets $3.500M $500.0K
YoY Change 600.0% 66.67%
Inventory $16.41M $9.300M
Prepaid Expenses $3.531M
Receivables $13.95M $8.100M
Other Receivables $0.00 $0.00
Total Short-Term Assets $62.88M $18.30M
YoY Change 243.62% 22.82%
LONG-TERM ASSETS
Property, Plant & Equipment $46.73M $11.50M
YoY Change 306.31% 11400.0%
Goodwill $4.922M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.925M $3.700M
YoY Change -20.94% -7.5%
Total Long-Term Assets $76.99M $34.10M
YoY Change 125.78% 731.71%
TOTAL ASSETS
Total Short-Term Assets $62.88M $18.30M
Total Long-Term Assets $76.99M $34.10M
Total Assets $139.9M $52.40M
YoY Change 166.93% 175.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.00M $12.50M
YoY Change 108.0% 1685.71%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.417M $1.700M
YoY Change 42.2%
Total Short-Term Liabilities $29.23M $14.30M
YoY Change 104.41% 78.75%
LONG-TERM LIABILITIES
Long-Term Debt $40.17M $11.40M
YoY Change 252.4%
Other Long-Term Liabilities $5.400M $2.900M
YoY Change 86.21%
Total Long-Term Liabilities $40.17M $14.30M
YoY Change 180.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.23M $14.30M
Total Long-Term Liabilities $40.17M $14.30M
Total Liabilities $75.47M $28.90M
YoY Change 161.15% 256.79%
SHAREHOLDERS EQUITY
Retained Earnings $25.41M
YoY Change
Common Stock $25.02K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $64.62M $23.50M
YoY Change
Total Liabilities & Shareholders Equity $139.9M $52.40M
YoY Change 166.93% 175.79%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income $7.001M $1.891M
YoY Change 270.18% -1282.04%
Depreciation, Depletion And Amortization $1.070M $540.0K
YoY Change 98.15% 1250.0%
Cash From Operating Activities $220.0K -$1.610M
YoY Change -113.66% 3925.0%
INVESTING ACTIVITIES
Capital Expenditures -$1.860M -$460.0K
YoY Change 304.35% 253.85%
Acquisitions
YoY Change
Other Investing Activities -$28.76M -$30.00K
YoY Change 95766.67%
Cash From Investing Activities -$30.62M -$490.0K
YoY Change 6148.98% 276.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 45.03M 1.080M
YoY Change 4069.44% 2060.0%
NET CHANGE
Cash From Operating Activities 220.0K -1.610M
Cash From Investing Activities -30.62M -490.0K
Cash From Financing Activities 45.03M 1.080M
Net Change In Cash 14.63M -1.020M
YoY Change -1534.31% 750.0%
FREE CASH FLOW
Cash From Operating Activities $220.0K -$1.610M
Capital Expenditures -$1.860M -$460.0K
Free Cash Flow $2.080M -$1.150M
YoY Change -280.87% -1377.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
26004141 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14096185 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13952805 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11714813 USD
CY2014Q2 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
9335321 USD
CY2013Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
0 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39189263 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19579732 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
101378 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
94466 USD
CY2013Q4 us-gaap Assets
Assets
64546356 USD
CY2014Q2 us-gaap Assets
Assets
139873327 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
45451 USD
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1178626 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1210007 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1345220 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
675558 shares
CY2014Q2 us-gaap Assets Current
AssetsCurrent
62883087 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
24095621 USD
CY2014Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
76990240 USD
CY2013Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
40450735 USD
CY2014Q2 us-gaap Borrowed Funds
BorrowedFunds
43704475 USD
CY2013Q4 us-gaap Borrowed Funds
BorrowedFunds
8515698 USD
CY2013Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2014Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1959418 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2559830 USD
CY2014Q2 us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
6481051 USD
us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
6481051 USD
CY2013Q2 us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
0 USD
us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
0 USD
CY2013Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1850000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2014Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1850000 USD
CY2013Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
3220250 USD
CY2014Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5385250 USD
CY2014Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
809497 USD
CY2013Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
0 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19651831 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2678628 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
297228 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
807940 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
16973203 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-510712 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25019450 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21205609 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21205609 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25019450 shares
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
25019 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
21206 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
168 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
644 USD
us-gaap Cost Of Revenue
CostOfRevenue
105406112 USD
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
32556738 USD
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
63200942 USD
us-gaap Cost Of Revenue
CostOfRevenue
62341782 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
11000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5684000 USD
CY2014Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5684000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
378000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
378000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1800950 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1069035 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16733683 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15172816 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2395745 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4653829 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9663006 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6075517 USD
CY2013Q4 us-gaap Goodwill
Goodwill
4502743 USD
CY2014Q2 us-gaap Goodwill
Goodwill
4922353 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
8878680 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
2554664 USD
us-gaap Gross Profit
GrossProfit
14023168 USD
us-gaap Gross Profit
GrossProfit
6024422 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1903518 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7537848 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2993616 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6656702 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18751 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12248 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
21249 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9464956 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3669339 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
930490 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2237992 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
1027321 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
0 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
79806 USD
vtnrpk Proceedsfrom Warrantand Stock Option Exercises
ProceedsfromWarrantandStockOptionExercises
37501 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3679989 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3465205 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-950000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2717571 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
657235 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
112999 USD
us-gaap Interest Expense
InterestExpense
733046 USD
us-gaap Interest Expense
InterestExpense
219139 USD
us-gaap Interest Paid
InterestPaid
733046 USD
us-gaap Interest Paid
InterestPaid
199737 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
16412448 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
8540459 USD
CY2014Q2 us-gaap Liabilities
Liabilities
75471866 USD
CY2013Q4 us-gaap Liabilities
Liabilities
26210133 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64546356 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
139873327 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16053032 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
29230973 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1956847 USD
CY2014Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2417335 USD
CY2014Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
40173643 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6558851 USD
CY2013Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 USD
CY2014Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
304000 USD
CY2014Q2 us-gaap Minority Interest
MinorityInterest
-218747 USD
CY2013Q4 us-gaap Minority Interest
MinorityInterest
1191962 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1635372 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
44741782 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-402899 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31399981 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1527559 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3631402 USD
us-gaap Net Income Loss
NetIncomeLoss
2974865 USD
us-gaap Net Income Loss
NetIncomeLoss
7863247 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
1891270 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
7001082 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-325399 USD
CY2014Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-344380 USD
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2974865 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7863247 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-105401 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5737516 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
483750 shares
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
13328 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5812957 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-226977 USD
CY2014Q2 us-gaap Notes Payable
NotesPayable
2454944 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3220593 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2008919 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
843745 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1800332 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2925096 USD
CY2014Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
10866 USD
CY2013Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
40726 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
10866 USD
CY2014Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7 USD
CY2013Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7598 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
377 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
32888 USD
us-gaap Payments For Proceeds From Businesses And Interest In Affiliates
PaymentsForProceedsFromBusinessesAndInterestInAffiliates
28764099 USD
us-gaap Payments For Proceeds From Businesses And Interest In Affiliates
PaymentsForProceedsFromBusinessesAndInterestInAffiliates
67972 USD
us-gaap Payments For Proceeds From Previous Acquisition
PaymentsForProceedsFromPreviousAcquisition
0 USD
us-gaap Payments For Proceeds From Previous Acquisition
PaymentsForProceedsFromPreviousAcquisition
-675558 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2452157 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2635882 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1010485 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
675 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
1319 USD
CY2014Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3530682 USD
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1161721 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
15803000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
CY2014Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
15803000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
40509906 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-750000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
304000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
200125 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
10937 USD
us-gaap Profit Loss
ProfitLoss
2974865 USD
CY2014Q2 us-gaap Profit Loss
ProfitLoss
6656702 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
1891270 USD
us-gaap Profit Loss
ProfitLoss
7537848 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46725108 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15091176 USD
CY2013Q1 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
1025000 USD
CY2014Q2 us-gaap Reduction Of Short Term Capital Lease Obligations
ReductionOfShortTermCapitalLeaseObligations
2345363 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
9634029 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
922873 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
25405251 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
17542004 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
72079622 USD
us-gaap Sales Revenue Net
SalesRevenueNet
68366204 USD
us-gaap Sales Revenue Net
SalesRevenueNet
119429280 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
35111402 USD
vtnrpk Sharebased Compensation Arrangementby Sharebased Payment Award Non Option Equity Instruments Vested Number
SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsVestedNumber
0 shares
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8034935 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2395745 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12222836 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4653829 USD
us-gaap Share Based Compensation
ShareBasedCompensation
101378 USD
us-gaap Share Based Compensation
ShareBasedCompensation
94466 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
10.00
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.00
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.72
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y6M25D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P0Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
6250 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
833 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
0 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
7083 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
192127 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
91667 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
10.78
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
150000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1327163 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1410616 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2635417 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3060834 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.77
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.89
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1719792 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
8.43
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1719792 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
8.43
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.68
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.55
CY2014Q2 us-gaap Share Price
SharePrice
8.10
CY2014Q1 us-gaap Share Price
SharePrice
3.82
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
522691 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M19D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y11M26D
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
37144261 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
64620208 USD
vtnrpk Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableGrantDateFairValue
0 USD
CY2014Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
64401461 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38336223 USD
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
748000 USD
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19887288 shares
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y0M25D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y8M19D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
522691 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23879500 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19798989 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24847456 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22826102 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17243762 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17409034 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22025316 shares
vtnrpk Common Stock Voting Rights Numberof Votes Per Share
CommonStockVotingRightsNumberofVotesPerShare
1
vtnrpk Exercisable Weighted Average Remaining Contractual Life In Years
ExercisableWeightedAverageRemainingContractualLifeInYears
P0Y
CY2013Q4 vtnrpk Net Operating Losses Acquired As Result Of Merger
NetOperatingLossesAcquiredAsResultOfMerger
42000000 USD
vtnrpk Nol Expected To Be Utilized
NolExpectedToBeUtilized
2200000 USD
CY2013Q4 vtnrpk Nol Remaining Balance
NolRemainingBalance
30750000 USD
CY2013Q4 vtnrpk Nol Untilized
NolUntilized
11250000 USD
vtnrpk Number Of Payments
NumberOfPayments
60 Payment
vtnrpk Options To Purchase
OptionsToPurchase
906000 shares
CY2014Q2 vtnrpk Options To Purchase Shares Exercised Gross
OptionsToPurchaseSharesExercisedGross
483750 shares
CY2014Q2 vtnrpk Options To Purchase Shares Exercised Net
OptionsToPurchaseSharesExercisedNet
464148 shares
CY2014Q2 vtnrpk Optionsto Purchase Shares Exercise Adjustment
OptionstoPurchaseSharesExerciseAdjustment
186250 shares
vtnrpk Proceedsfrom Warrantand Stock Option Exercises
ProceedsfromWarrantandStockOptionExercises
211062 USD
vtnrpk Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledGrantDateFairValue
100 USD
vtnrpk Sharebased Compensation Arrangementby Sharebased Payment Award Options Grantsin Period Intrinsic Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsinPeriodIntrinsicValue
304915 USD
CY2013Q4 vtnrpk Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue
2900 USD
vtnrpk Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodFairValue
29335 USD
CY2014Q2 vtnrpk Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Otherthan Options Exercisablein Period
SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsExercisableinPeriod
0 shares
vtnrpk Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Otherthan Options Exercisedin Period Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsExercisedinPeriodWeightedAverageGrantDateFairValue
1.75
vtnrpk Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Otherthan Options Exercisesin Period Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsExercisesinPeriodWeightedAverageGrantDateFairValue
2800 USD
CY2014Q2 vtnrpk Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue
0 USD
CY2014Q2 vtnrpk Stock Offering Costs
StockOfferingCosts
1247000 USD
vtnrpk Stock Options Exercised During Period Aggregate Exercise Price
StockOptionsExercisedDuringPeriodAggregateExercisePrice
130625 USD
vtnrpk Vested Weighted Average Remaining Contractual Life In Years
VestedWeightedAverageRemainingContractualLifeInYears
P0Y
CY2014Q2 vtnrpk Warrants And Options Exercised Net
WarrantsAndOptionsExercisedNet
6250 shares
CY2014Q2 vtnrpk Warrants And Options Exercised Shares
WarrantsAndOptionsExercisedShares
6250 shares
CY2014Q2 vtnrpk Warrants Exercisable Weighted Average Exercise Price
WarrantsExercisableWeightedAverageExercisePrice
0.00
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000890447
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25042210 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
Vertex Energy Inc.

Files In Submission

Name View Source Status
0001445305-14-003679-index-headers.html Edgar Link pending
0001445305-14-003679-index.html Edgar Link pending
0001445305-14-003679.txt Edgar Link pending
0001445305-14-003679-xbrl.zip Edgar Link pending
a3312014-d_chartx06028a01.jpg Edgar Link pending
a6302014-document.htm Edgar Link pending
a6302014-ex311.htm Edgar Link pending
a6302014-ex312.htm Edgar Link pending
a6302014-ex321.htm Edgar Link pending
a6302014-ex322.htm Edgar Link pending
a6302014-ex992.htm Edgar Link pending
ex1022landlease-marreroter.htm Edgar Link pending
ex1023myrtlegroveleasewexh.htm Edgar Link pending
ex1024omega-operationmanag.htm Edgar Link pending
ex1025tsa-omegaxmtb.htm Edgar Link pending
ex1026omegabangopurchasean.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
firstamendsig1.jpg Edgar Link pending
firstamendsig2.jpg Edgar Link pending
firstamendsiteplan.jpg Edgar Link pending
landleaseland1.jpg Edgar Link pending
landleaseland10.jpg Edgar Link pending
landleaseland11.jpg Edgar Link pending
landleaseland2.jpg Edgar Link pending
landleaseland3.jpg Edgar Link pending
landleaseland4a01.jpg Edgar Link pending
landleaseland5.jpg Edgar Link pending
landleaseland6.jpg Edgar Link pending
landleaseland7.jpg Edgar Link pending
landleaseland8.jpg Edgar Link pending
landleasesig1.jpg Edgar Link pending
myrtleplan1.jpg Edgar Link pending
myrtlesig1.jpg Edgar Link pending
myrtlesig2.jpg Edgar Link pending
omegabango1.jpg Edgar Link pending
omegabango10.jpg Edgar Link pending
omegabango11.jpg Edgar Link pending
omegabango2.jpg Edgar Link pending
omegabango3.jpg Edgar Link pending
omegabango4.jpg Edgar Link pending
omegabango5.jpg Edgar Link pending
omegabango6.jpg Edgar Link pending
omegabango7.jpg Edgar Link pending
omegabango8.jpg Edgar Link pending
omegabango9.jpg Edgar Link pending
omegaplan1.jpg Edgar Link pending
omegasig1.jpg Edgar Link pending
plaqueminesandomegasignature.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
secondamend1.jpg Edgar Link pending
secondamend2.jpg Edgar Link pending
Show.js Edgar Link pending
tsaomegamtbimage2.gif Edgar Link pending
tsasig1.jpg Edgar Link pending
vtnrpk-20140630.xml Edgar Link completed
vtnrpk-20140630.xsd Edgar Link pending
vtnrpk-20140630_cal.xml Edgar Link unprocessable
vtnrpk-20140630_def.xml Edgar Link unprocessable
vtnrpk-20140630_lab.xml Edgar Link unprocessable
vtnrpk-20140630_pre.xml Edgar Link unprocessable